Search

everythinglearnresearchcommunity

for

Search:↓

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

A machine learning model can predict alopecia areata early using specific gene markers.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

Ayurvedic treatments can effectively regrow hair in alopecia areata.

The study suggests that hypothyroidism may cause alopecia areata.

Homeopathic treatment might help manage alopecia areata.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

A man with severe hair loss regrew hair after hormone treatment.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.